Search Results

There are 95463 results for: content related to: To B or not to B cells-mediate a healthy start to life

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    Monoclonal antibodies in treatment of multiple sclerosis

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 373–384, P. S. Rommer, A. Dudesek, O. Stüve and U.K. Zettl

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12197

  3. You have free access to this content
    Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study

    Clinical & Experimental Immunology

    Volume 180, Issue 1, April 2015, Pages: 11–18, A.-P. Trouvin, S. Jacquot, S. Grigioni, E. Curis, I. Dedreux, A. Roucheux, H. Boulard, O. Vittecoq, X. Le Loët, O. Boyer and V. Goëb

    Version of Record online : 10 MAR 2015, DOI: 10.1111/cei.12481

  4. Experience with low-dose rituximab in off-label indications at two tertiary hospitals

    Internal Medicine Journal

    Volume 43, Issue 8, August 2013, Pages: 871–882, J. Chay, P. Donovan, L. Cummins, P. Kubler and P. Pillans

    Version of Record online : 6 AUG 2013, DOI: 10.1111/imj.12207

  5. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  6. You have free access to this content
    Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system

    Clinical & Experimental Immunology

    Volume 176, Issue 2, May 2014, Pages: 135–148, A. Salmen, R. Gold and A. Chan

    Version of Record online : 9 APR 2014, DOI: 10.1111/cei.12258

  7. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  8. You have free access to this content
    2017 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 69, Issue S10, October 2017, Pages: 1–4426,

    Version of Record online : 27 SEP 2017, DOI: 10.1002/art.40321

  9. Aggressive Non-Hodgkin's Lymphomas

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt003

  10. You have free access to this content
    Myasthenia gravis: an update for the clinician

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 408–418, J. P. Sieb

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12217

  11. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x

  12. You have free access to this content
    Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura

    Clinical & Experimental Immunology

    Volume 179, Issue 3, March 2015, Pages: 414–425, E. Becerra, M. A. Scully, M. J. Leandro, E. O. Heelas, J.-P. Westwood, I. De La Torre and G. Cambridge

    Version of Record online : 16 FEB 2015, DOI: 10.1111/cei.12472

  13. You have free access to this content
    Reduced CD5+CD24hiCD38hi and interleukin-10+ regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies

    Clinical & Experimental Immunology

    Volume 180, Issue 2, May 2015, Pages: 178–188, L. T. Aybar, J. G. McGregor, S. L. Hogan, Y. Hu, C. E. Mendoza, E. J. Brant, C. J. Poulton, C. D. Henderson, R. J. Falk and D. O. Bunch

    Version of Record online : 14 APR 2015, DOI: 10.1111/cei.12483

  14. You have free access to this content
    Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum

    Clinical & Experimental Immunology

    Volume 175, Issue 2, February 2014, Pages: 150–166, G. A. Ramirez, N. Maugeri, M. G. Sabbadini, P. Rovere-Querini and A. A. Manfredi

    Version of Record online : 3 JAN 2014, DOI: 10.1111/cei.12223

  15. You have free access to this content
    Increased 8-hydroxy-2′-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus

    Clinical & Experimental Immunology

    Volume 176, Issue 1, April 2014, Pages: 66–77, H.-T. Lee, C.-S. Lin, C.-S. Lee, C.-Y. Tsai and Y.-H. Wei

    Version of Record online : 6 MAR 2014, DOI: 10.1111/cei.12256

  16. You have free access to this content
    Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  17. You have free access to this content
    Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

    Clinical & Experimental Immunology

    Volume 178, Issue 1, October 2014, Pages: 40–47, J. Westra, S. van Assen, K. R. Wilting, J. Land, G. Horst, A. de Haan and M. Bijl

    Version of Record online : 4 SEP 2014, DOI: 10.1111/cei.12390

  18. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  19. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  20. You have free access to this content
    Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12498